Retrotraid Causes Crisis in Egypt
The spread of "Retatrutide" products on social media platforms, especially TikTok, in Egypt has sparked widespread controversy. Some pages promote it as a quick-fix solution for weight loss with remarkable results. However, the Egyptian Drug Authority has warned that "Retatrutide" is an experimental substance still under development and has not received final approval for commercial use. The authority is actively working to identify those illegally promoting it and to take legal action. Clinical trial results suggest that the substance has the potential to reduce weight and improve metabolic indicators, but the products currently available are unauthorized and could pose health risks, such as dehydration, disturbances in sodium and potassium levels, kidney problems, and gastrointestinal issues—especially if they are of unknown origin or stored improperly. Therefore, the authority advises against the random use of these products and emphasizes that all study results relate to a substance still in the experimental stage, and it cannot be considered an approved treatment at this time.
Notice: This Is an AI-Generated Summary
Comments (0)